Akebia Therapeutics Inc. (AKBA) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Akebia Therapeutics Inc. (AKBA) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on AKBA
4 stocks to watch 2:33 p.m. April 16, 2014 - The Trading Deck
Biotech IPOs manage double-digit gains on first days of trading 11:47 a.m. March 21, 2014 - Russ Britt

Other News on AKBA
10-Q: AKEBIA THERAPEUTICS, INC. 7:03 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Akebia renal anemia drug successful in Phase 2 6:13 a.m. Oct. 27, 2014 - Seeking Alpha
First patient dosed in Phase 2 trial of Akebia's lead product 9:59 a.m. Sept. 25, 2014 - Seeking Alpha
Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8% - Tale of the Tape 7:57 a.m. Sept. 16, 2014 - Zacks.com
Others Overlooked Akebia Therapeutics (AKBA), Should You Buy It Now? - Tale of the Tape 7:45 a.m. Sept. 15, 2014 - Zacks.com
Significant Sell-Off Could Occur For Akebia Therapeutics At Lockup Expiration 4:50 p.m. Sept. 3, 2014 - Seeking Alpha
Can the Uptrend Continue for Akebia (AKBA)? - Tale of the Tape 8:33 a.m. Aug. 18, 2014 - Zacks.com
10-Q: AKEBIA THERAPEUTICS, INC. 6:28 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hidden Value From Abnormal Insider Buying Activity 3:54 a.m. June 10, 2014 - Seeking Alpha
10-Q: AKEBIA THERAPEUTICS, INC. 6:08 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Halliburton Feels The Turn (4/22/14) 5:08 a.m. April 23, 2014 - Seeking Alpha
Why Akebia Therapeutics (AKBA) Stock Soared Today 3:21 p.m. April 14, 2014 - TheStreet.com
Weekly CEO Buys Highlight: BH, OPK, ARCP, RSE, AKBA 5:02 p.m. April 1, 2014 - GuruFocus.com
IPO Sizzle Continues With A10 Networks Set For Friday 12:03 p.m. March 20, 2014 - Investors Business Daily
Press Releases on AKBA
Akebia Therapeutics President and Chief Executive Officer Establishes Stock Purchase Plan 7:01 a.m. Nov. 17, 2014 - BusinessWire - BZX
Akebia Announces Poster Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting 7:00 a.m. Nov. 11, 2014 - BusinessWire - BZX
Akebia Announces Third Quarter 2014 Financial Results 7:01 a.m. Nov. 10, 2014 - BusinessWire - BZX
Akebia to Participate in Upcoming Investor Conferences 6:01 a.m. Oct. 31, 2014 - BusinessWire - BZX
Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease 5:30 a.m. Oct. 27, 2014 - BusinessWire - BZX
Akebia Announces Dosing of First Patient in Phase 2 Study of AKB-6548 in Patients with Anemia Related to Chronic Kidney Disease Undergoing Dialysis 6:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Akebia Therapeutics Appoints Ronald C. Renaud Jr. to its Board of Directors 6:15 a.m. Sept. 15, 2014 - BusinessWire - BZX
Akebia Therapeutics, Inc. (NASDAQ: AKBA) to Ring The NASDAQ Stock Market Opening Bell 9:00 a.m. Sept. 11, 2014 - GlobeNewswire
Akebia to Participate in Upcoming Investor Conferences 6:01 a.m. Aug. 27, 2014 - BusinessWire - BZX
Akebia Announces Second Quarter 2014 Financial Results 6:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Expansion of Management Team 6:01 a.m. Aug. 6, 2014 - BusinessWire - BZX
Akebia Therapeutics Appoints Michael Clayman, M.D. and Maxine Gowen, Ph.D. to its Board of Directors 6:02 a.m. July 17, 2014 - BusinessWire - BZX
Akebia Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 6:01 a.m. June 30, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Upcoming Presentation at 51st ERA-EDTA Annual Congress 6:02 a.m. May 29, 2014 - BusinessWire - BZX
Akebia to Present at the Annual UBS Global Healthcare Conference 8:32 a.m. May 12, 2014 - BusinessWire - BZX
Akebia Announces First Quarter 2014 Financial Results and Recent Corporate Highlights 6:01 a.m. May 12, 2014 - BusinessWire - BZX
Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate Updates - Analyst Notes on Insmed, Akebia, Retrophin, Agios and Spectranetics 7:00 a.m. April 23, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Aruba Networks, Akebia Therapeutics, bebe stores, and Allscripts Healthcare Solutions 11:03 a.m. April 15, 2014 - PR Newswire - PRF
Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-6548 8:21 a.m. April 15, 2014 - BusinessWire - BZX
Akebia Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 7:02 a.m. March 26, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Victor Care Networks Explores Transformative Mental Health

Updated Category News Views 3

Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...

Continue Reading
Allooloo's AI Zones Transform Financial Services Agent

Updated Category News Views 3

The Allure of AI Agents in Finance Ah, it's a brave new world, my friend. A hundred years ago, the financial services industry relied on flesh-and-blood analysts armed with pens and filing cabinets. Today? It's all about AI agents, and Allooloo Technologies Corp. is at the heart of the action. Just recently, they rolled out specialized zones of record for AI—datasets...

Continue Reading
Honeywell Aerospace Faces Investor Class Action Lawsuit

Updated Category News Views 5

Smoke and Mirrors: Honeywell's Legal Trouble Okay, here's a fun way to start your day: talking lawsuits. Honeywell Aerospace Inc. (NASDAQ:HONA), a name you'd know if you're into aircraft components and avionics, is in hot water. It seems they've been less than transparent about their business prospects, prompting a class action lawsuit from open market purchasers during a...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 3

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Amber Intl Unveils AGM Outcomes, Strategic Moves

Updated Category News Views 2

Diving Into Amber International's AGM Decisions Ah, the hum of shareholder meetings—a fancy little dance of approvals and resolutions! That's exactly what went down on October 23, 2026, for Amber International Holding Limited. A fresh roster, some hefty share awards, and strategic decisions wrapped up their recent annual gathering. Shed the lawyer-speak and let's get...

Continue Reading
Graybar's Integrity Shines: Forbes Honors Trust Again

Updated Category News Views 3

Trust Is Graybar's Secret Sauce Graybar's been hauling the trust trophy back home from Forbes for the second year straight. This ain't just another fleeting accolade—the kind you hang on the office wall without meaning it. What's brewing here is more profound, nestled in the heart of St. Louis and bubbling through its logistics veins. Being named one of Forbes' 2027...

Continue Reading
Oakworth Capital's Strategic Gains: A Deep Dive

Updated Category News Views 2

Oakworth Capital's Big Moves This Quarter Diving right into the Alabama-based Oakworth Capital's latest numbers, they did not pull any punches with a hefty 19% bump in net income. Now, in a world where banking can sometimes feel like riding a porcupine, Oakworth's ability to rise above speaks volumes. They clocked in at $17.2 million net income for the year-to-date period...

Continue Reading
Cole Haan Opens 600th Store, Makes Boston Comeback

Updated Category News Views 6

A Milestone and a Homecoming Who would've thought? Cole Haan, the American staple that seems to draw from an old-world charm and modern flair, is making waves again. They've just hit their 600th store mark—a number not to scoff at, especially when retail's felt the squeeze lately. But it’s not just about another number. It’s about a return, a resounding "we still...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 5

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading

Top 5 Most Recently Viewed Articles

Avanos Medical Appoints Camille Chang Gilmore as HR Leader

Updated Category News Views 231

Avanos Medical Welcomes Camille Chang Gilmore Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the medical technology industry renowned for its innovative healthcare solutions, is excited to share the news of Camille Chang Gilmore's appointment as Senior Vice President and Chief Human Resources Officer. This strategic decision underscores Avanos' commitment to...

Continue Reading
Unlocking Efficiency in Convenience Stores with Square 9

Updated Category News Views 152

Empowering Convenience Stores to Thrive The convenience store industry is experiencing robust growth, presenting both opportunities and challenges for business owners. Amidst this evolving landscape, Square 9 Softworks steps up as a knowledgeable ally, offering powerful insights through its latest expert guide designed specifically for C-stores. This essential resource...

Continue Reading
CREATEA Launches Innovative Mighty Mango Beverage Concept

Updated Category News Views 256

Unveiling of CREATEA Mighty Mango Concept Beverage CREATEA is set to turn heads with the introduction of its Mighty Mango beverage at SupplySide Global 2025. This innovative drink combines a unique formula that not only promotes physical performance through creatine but also enhances mental energy with scientifically-supported ingredients. The 12 oz ready-to-drink...

Continue Reading
Performance Brokerage Services Facilitates Mark Chevrolet Sale

Updated Category News Views 204

Performance Brokerage Services Facilitates Dealership Sale Performance Brokerage Services, a leader in dealership buy-sell activities, recently announced the successful sale of Mark Chevrolet. The transition involved Charles Cabana, the former owner, and Bill Golling, associated with the prominent Golling Automotive Group. A Legacy of Service at Mark Chevrolet Mark...

Continue Reading
Dillard's Stock Takes a Hit: Key Insights and Trends

Updated Category News Views 153

Stock Slump: What Gives? Look, I’ve been in this game long enough to know when a company’s got its back against the wall. Dillard’s is feeling the heat, and today it’s clear: the department store operator isn’t exactly riding high on the hog. Their stock, Dillard's (DDS), took a nosedive of 7.18% and is sitting at $599.80. Why? Well, it boils down to mixed...

Continue Reading